Tokyo, Nov. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059639) titled 'Effect of Chocolate Odor on Appetite and Resistance Exercise Performance in the Fasted State' on Nov. 4.

Study Type: Interventional

Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - Faculty of Sports and Exercise Science, Universiti Malaya

Condition: Condition - Appetite regulation and exercise performance in the fasted state (healthy adults) Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - This study aims to investigate the effects of chocolate odors (dark and milk chocolate) on appetite perception and resistance exercise performance in the fasted state. The objective is to determine whether olfactory stimulation can modulate exercise capacity through appetite-related and affective pathways. Basic objectives2 - Others

Intervention: Interventions/Control_1 - Participants are exposed to a 90% dark chocolate odor for 30 seconds as an olfactory stimulus, followed by appetite assessment (VAS) and resistance exercise (leg extension task). Interventions/Control_2 - Participants are exposed to a 60% milk chocolate odor for 30 seconds as an olfactory stimulus, followed by appetite assessment (VAS) and resistance exercise performance test.

Eligibility: Age-lower limit - 18 years-old = Gender - Male Key inclusion criteria - Healthy adult men, 18-30 years Moderately trained: resistance training >=2 sessions/week for >=2 years Non-smokers Normal olfactory function (self-reported; no known smell disorder) Able to attend sessions in the fasted state (8-10 h) No known allergy to chocolate odors or solvent (propylene glycol) Provided written informed consent Key exclusion criteria - History or current diagnosis of metabolic, cardiovascular, neurological, or respiratory diseases Musculoskeletal injuries or pain that may limit resistance exercise performance Use of medications or supplements that could influence appetite, olfaction, or performance (e.g., appetite suppressants, stimulants, or caffeine intake on the test day) Presence of olfactory dysfunction, acute upper respiratory infection, or severe allergic rhinitis Known allergy to chocolate, cocoa, or propylene glycol Target Size - 23

Recruitment Status: Recruitment status - Completed Date of protocol fixation - 2024 Year 06 Month 18 Day Date of IRB - 2025 Year 07 Month 12 Day Anticipated trial start date - 2025 Year 07 Month 18 Day Last follow-up date - 2025 Year 12 Month 18 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068210

Disclaimer: Curated by HT Syndication.